Catherine M.  Burzik net worth and biography

Catherine Burzik Biography and Net Worth

Director of Orthofix Medical
Catherine M. Burzik is a businessperson who has been at the helm of 10 different companies and is Chairman at Orthofix Medical, Inc., Chairman for StemBioSys, Inc., Chairman for Gemini Bioproducts LLC and President & Chief Executive Officer at CFB Interests LLC. Ms. Burzik is also Chairman for American College of Wound Healing & Tissue Repair and on the board of 7 other companies.

She previously held the position of President & Chief Executive Officer for Kodak Health Imaging Systems, Inc., Principal at Eastman Kodak Co., General Manager-Critikon Business at Johnson & Johnson, President, Chief Executive Officer & Director at Kinetic Concepts, Inc., President for Applied Biosystems, Inc., President for Ortho-Clinical Diagnostics, Inc., Senior Vice President for Applera Corp., Chairman-San Antonio Branch at Federal Reserve Bank of Dallas and General Partner of Targeted Technology Fund II LP.

Ms. Burzik received an undergraduate degree from Canisius College and a graduate degree from State University of New York at Buffalo.

How do I contact Catherine M. Burzik?

The corporate mailing address for Ms. Burzik and other Orthofix Medical executives is 3451 Plano Parkway, Lewisville TX, 75056. Orthofix Medical can also be reached via phone at (214) 937-2000 and via email at [email protected]. Learn More on Catherine M. Burzik's contact information.

Has Catherine M. Burzik been buying or selling shares of Orthofix Medical?

Catherine M. Burzik has not been actively trading shares of Orthofix Medical in the last ninety days. Most recently, on Friday, November 19th, Catherine M. Burzik bought 1,660 shares of Orthofix Medical stock. The stock was acquired at an average cost of $30.27 per share, with a total value of $50,248.20. Learn More on Catherine M. Burzik's trading history.

Who are Orthofix Medical's active insiders?

Orthofix Medical's insider roster includes Catherine Burzik (Director), Rice Doug (CFO), Kimberley Elting (Insider), Michael Paolucci (Director), and Jon Serbousek (CEO). Learn More on Orthofix Medical's active insiders.

Are insiders buying or selling shares of Orthofix Medical?

In the last year, Orthofix Medical insiders bought shares 1 times. They purchased a total of 7,500 shares worth more than $101,025.00. In the last year, insiders at the medical device company sold shares 2 times. They sold a total of 8,243 shares worth more than $156,617.00. The most recent insider tranaction occured on September, 14th when Director James F Hinrichs bought 7,500 shares worth more than $101,025.00. Insiders at Orthofix Medical own 4.7% of the company. Learn More about insider trades at Orthofix Medical.

Information on this page was last updated on 9/14/2023.

Catherine M. Burzik Insider Trading History at Orthofix Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2021Buy1,660$30.27$50,248.20View SEC Filing Icon  
See Full Table

Catherine M. Burzik Buying and Selling Activity at Orthofix Medical

This chart shows Catherine M Burzik's buying and selling at Orthofix Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Orthofix Medical Company Overview

Orthofix Medical logo
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Read More

Today's Range

Now: $14.52
Low: $14.22
High: $14.76

50 Day Range

MA: $13.91
Low: $13.00
High: $14.62

2 Week Range

Now: $14.52
Low: $9.57
High: $21.60

Volume

248,060 shs

Average Volume

443,676 shs

Market Capitalization

$543.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03